Thomas J. Garrity, Director at ANTARES PHARMA, INC. (ATRS), sold 40,000 shares at $4.58 ($183K) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $183k ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2021-01-13 | $284K | — | Filing → |
| ATRS | SELL | 2019-05-03 | $80K | — | Filing → |
| ATRS | SELL | 2017-10-05 | $105K | — | Filing → |